NATCO Pharma Statistics

Total Valuation

NATCO Pharma has a market cap or net worth of INR 253.79 billion. The enterprise value is 231.31 billion.

Market Cap	253.79B
Enterprise Value	231.31B

Important Dates

The next estimated earnings date is Tuesday, February 11, 2025.

Earnings Date	Feb 11, 2025
Ex-Dividend Date	Nov 27, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.16%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	80.40M

Valuation Ratios

The trailing PE ratio is 13.05.

PE Ratio	13.05
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	3.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.74, with an EV/FCF ratio of 17.06.

EV / Earnings	11.89
EV / Sales	5.07
EV / EBITDA	9.74
EV / EBIT	10.56
EV / FCF	17.06

Financial Position

The company has a current ratio of 4.96, with a Debt / Equity ratio of 0.03.

Current Ratio	4.96
Quick Ratio	3.87
Debt / Equity	0.03
Debt / EBITDA	0.09
Debt / FCF	0.15
Interest Coverage	103.34

Financial Efficiency

Return on equity (ROE) is 31.23% and return on invested capital (ROIC) is 21.22%.

Return on Equity (ROE)	31.23%
Return on Assets (ROA)	18.89%
Return on Capital (ROIC)	21.22%
Revenue Per Employee	11.36M
Profits Per Employee	4.84M
Employee Count	4,016
Asset Turnover	0.63
Inventory Turnover	0.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +82.20% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+82.20%
50-Day Moving Average	1,399.86
200-Day Moving Average	1,252.61
Relative Strength Index (RSI)	48.78
Average Volume (20 Days)	44,229

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NATCO Pharma had revenue of INR 45.64 billion and earned 19.45 billion in profits. Earnings per share was 108.58.

Revenue	45.64B
Gross Profit	38.69B
Operating Income	21.91B
Pretax Income	23.56B
Net Income	19.45B
EBITDA	23.74B
EBIT	21.91B
Earnings Per Share (EPS)	108.58

Full Income Statement

Balance Sheet

The company has 24.63 billion in cash and 2.08 billion in debt, giving a net cash position of 22.55 billion.

Cash & Cash Equivalents	24.63B
Total Debt	2.08B
Net Cash	22.55B
Net Cash Per Share	n/a
Equity (Book Value)	71.57B
Book Value Per Share	399.14
Working Capital	39.93B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.16 billion and capital expenditures -3.60 billion, giving a free cash flow of 13.56 billion.

Operating Cash Flow	17.16B
Capital Expenditures	-3.60B
Free Cash Flow	13.56B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 84.78%, with operating and profit margins of 48.01% and 42.61%.

Gross Margin	84.78%
Operating Margin	48.01%
Pretax Margin	51.62%
Profit Margin	42.61%
EBITDA Margin	52.01%
EBIT Margin	48.01%
FCF Margin	29.72%

Dividends & Yields

NATCO Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-45.45%
Years of Dividend Growth	2
Payout Ratio	5.10%
Buyback Yield	1.16%
Shareholder Yield	1.16%
Earnings Yield	7.65%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on November 26, 2015. It was a forward split with a ratio of 5.

Last Split Date	Nov 26, 2015
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a